Enzalutamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

48 Suppliers, 22 USDMF, 6 EU WC, 6 KDMF, 15 NDC API, 36 Listed Suppliers

DEVELOPMENTS

50 Drug(s) in Development

50 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

30 Suppliers

30 Suppliers

DOSSIERs // Finished Dosage Forms

25 Dossiers, 7 FDA Orange Book, 3 Europe, 1 Canada, 3 Australia, 1 South Africa, 10 Listed Dossiers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

6 APIs, 10 DOSSIERS // FDF

PATENTS

26 US Patents, 3 US Exclusivities, 1 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 174 News

Annual Sales of Enzalutamide reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Enzalutamide

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

48 Suppliers

22 USDMF

6 EU WC

6 KDMF

15 NDC API

36 Listed Suppliers

DEVELOPMENTS

50 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

30 Suppliers

DOSSIERs // Finished Dosage Forms

25 Dossiers

7 FDA Orange Book

3 Europe

1 Canada

3 Australia

1 South Africa

10 Listed Dossiers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

2 Finished Drug Prices

MARKET PLACE

6 APIs

10 DOSSIERS // FDF

PATENTS

26 US Patents

3 US Exclusivities

1 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow

174 News

Enzalutamide

Astellas

Enzalutamide

Xtandi

Oncology

YEN

328

269

2,950

2,423

527

22%

Pfizer

Enzalutamide

Xtandi Alliance Revenues

Oncology

USD

699

590

699

590

109

18%